Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014 (2014), Article ID 312452, 9 pages
http://dx.doi.org/10.1155/2014/312452
Research Article

Liraglutide Exerts Antidiabetic Effect via PTP1B and PI3K/Akt2 Signaling Pathway in Skeletal Muscle of KKAy Mice

1College of Medicine, Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China
2Xi’an No. 1 Hospital, Xi’an, Shaanxi 710002, China

Received 17 June 2014; Revised 22 July 2014; Accepted 22 July 2014; Published 11 August 2014

Academic Editor: Khalid Hussain

Copyright © 2014 Wenjun Ji et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Yang, J. Lu, J. Weng et al., “Prevalence of diabetes among men and women in China,” The New England Journal of Medicine, vol. 362, no. 12, pp. 1090–1101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. B. R. Mehra, A. P. Thawait, S. S. Karandikar, D. O. Gupta, and R. R. Narang, “Evaluation of foot problems among diabetics in rural population,” Indian Journal of Surgery, vol. 70, no. 4, pp. 175–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. A. Ma, Z. Zhao, and J. Turk, “Mitochondrial dysfunction and β-cell failure in type 2 diabetes mellitus,” Experimental Diabetes Research, vol. 2012, Article ID 703538, 11 pages, 2012. View at Publisher · View at Google Scholar
  4. L. S. Dalboge, D. L. Almholt, T. S. Neerup et al., “The novel GLP-1-Gastrin dual agonist ZP3022 improves glucose homeostasis and increases beta-cell mass without affecting Islet number in db/db mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 350, no. 2, pp. 353–360, 2014. View at Google Scholar
  5. Y. Fujishima, N. Maeda, K. Inoue et al., “Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes,” Cardiovascular Diabetology, vol. 11, article 107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Matsumoto, M. Yamazaki, M. Kadono et al., “Effects of liraglutide on postprandial insulin and glucagon responses in Japanese patients with type 2 diabetes,” Journal of Clinical Biochemistry and Nutrition, vol. 53, no. 1, pp. 68–72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. L. V. Jacobsen, C. Hindsberger, R. Robson, and M. Zdravkovic, “Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide,” British Journal of Clinical Pharmacology, vol. 68, no. 6, pp. 898–905, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Flint, C. Kapitza, C. Hindsberger, and M. Zdravkovic, “The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients,” Advances in Therapy, vol. 28, no. 3, pp. 213–226, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. H. M. de Wit, G. M. Vervoort, H. J. Jansen et al., “Liraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT),” Diabetologia, vol. 57, no. 9, pp. 1812–1819, 2014. View at Google Scholar
  10. R. C. Tsou and K. K. Bence, “Central regulation of metabolism by protein tyrosine phosphatases,” Frontiers in Neuroscience, vol. 6, article 192, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Kirk-Ballard, Z. Q. Wang, P. Acharya et al., “An extract of Artemisia dracunculus L. inhibits ubiquitin-proteasome activity and preserves skeletal muscle mass in a murine model of diabetes,” PLoS ONE, vol. 8, no. 2, Article ID e57112, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Osorio-Fuentealba, A. E. Contreras-Ferrat, F. Altamirano et al., “Electrical stimuli release ATP to increase GLUT4 translocation and glucose uptake via PI3Kγ-Akt-AS160 in skeletal muscle cells,” Diabetes, vol. 62, no. 5, pp. 1519–1526, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. A. J. Stull, Z. Q. Wang, X. H. Zhang, Y. Yu, W. D. Johnson, and W. T. Cefalu, “Skeletal muscle protein tyrosine phosphatase 1B regulates insulin sensitivity in African Americans,” Diabetes, vol. 61, no. 6, pp. 1415–1422, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. L. N. Chen, J. Lyu, X. F. Yang et al., “Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in diabetic KKAy mice,” International Journal of Molecular Medicine, vol. 32, no. 4, pp. 892–900, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Chodavarapu, N. Grobe, H. K. Somineni, E. S. B. Salem, M. Madhu, and K. M. Elased, “Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion,” PLoS ONE, vol. 8, no. 4, Article ID e62833, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Wang, X. C. Wang, L. Zhao et al., “Oligonucleotide microarray analysis reveals dysregulation of energy-related metabolism in insulin-sensitive tissues of type 2 diabetes patients,” Genetics and Molecular Research, vol. 13, no. 2, pp. 4494–4504, 2014. View at Publisher · View at Google Scholar
  17. S. Sipal, Z. Halici, I. Kiki et al., “Comparative study of three angiotensin II type 1 receptor antagonists in preventing liver fibrosis in diabetic rats: stereology, histopathology, and electron microscopy,” Journal of Molecular Histology, vol. 43, no. 6, pp. 723–735, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Hastie and M. Lappas, “The effect of pre-existing maternal obesity and diabetes on placental mitochondrial content and electron transport chain activity,” Placenta, 2014. View at Publisher · View at Google Scholar
  19. G. P. Holloway, B. J. Gurd, L. A. Snook, J. Lally, and A. Bonen, “Compensatory increases in nuclear PGC1α protein are primarily associated with subsarcolemmal mitochondrial adaptations in ZDF rats,” Diabetes, vol. 59, no. 4, pp. 819–828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Kesavadev, A. Shankar, G. Krishnan, and S. Jothydev, “Liraglutide therapy beyond glycemic control: an observational study in Indian patients with type 2 diabetes in real world setting,” International Journal of General Medicine, vol. 5, pp. 317–322, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. H. He, X. Qiao, and S. Wu, “Carbamylated erythropoietin attenuates cardiomyopathy via PI3K/Akt activation in rats with diabetic cardiomyopathy,” Experimental and Therapeutic Medicine, vol. 6, no. 2, pp. 567–573, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Cao, B. Li, X. Yi et al., “Effects of exercise on AMPK signaling and downstream components to PI3K in rat with type 2 diabetes,” PLoS ONE, vol. 7, no. 12, Article ID e51709, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Zhang, R. Li, J. Li et al., “α-linolenic acid exerts an endothelial protective effect against high glucose injury via PI3K/Akt pathway,” PLoS ONE, vol. 8, no. 7, Article ID e68489, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. Á. González-Rodríguez, J. A. Mas Gutierrez, S. Sanz-González, M. Ros, D. J. Burks, and Á. M. Valverde, “Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice,” Diabetes, vol. 59, no. 3, pp. 588–599, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Salmeen and D. Barford, “Functions and mechanisms of redox regulation of cysteine-based phosphatases,” Antioxidants and Redox Signaling, vol. 7, no. 5-6, pp. 560–577, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Lungkaphin, P. Arjinajarn, A. Pongchaidecha et al., “Impaired insulin signaling affects renal organic anion transporter 3 (Oat3) function in streptozotocin-induced diabetic rats,” PLoS ONE, vol. 9, no. 5, Article ID e96236, 2014. View at Google Scholar
  27. X. Li, G. Zhao, B. Ma et al., “20-Hydroxyeicosatetraenoic acid impairs endothelial insulin signaling by inducing phosphorylation of the insulin receptor substrate-1 at Ser616,” PLoS ONE, vol. 9, no. 4, Article ID e95841, 2014. View at Google Scholar
  28. P. Mertins, H. C. Eberl, J. Renkawitz et al., “Investigation of protein-tyrosine phosphatase 1B function by quantitative proteomics,” Molecular and Cellular Proteomics, vol. 7, no. 9, pp. 1763–1777, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. M. Swarbrick, P. J. Havel, A. A. Levin et al., “Inhibition of protein tyrosine phosphatase-IB with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeys,” Endocrinology, vol. 150, no. 4, pp. 1670–1679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. Wang, J. Hou, and L. Lu, “Small ribosomal protein subunit S7 suppresses ovarian tumorigenesis through regulation of the PI3K/AKT and MAPK pathways,” PLoS ONE, vol. 8, no. 11, Article ID e79117, 2013. View at Google Scholar
  31. Z. Zhang, C. Liu, Z. Gan et al., “Improved glucose-stimulated insulin secretion by selective intraislet inhibition of angiotensin II type 1 receptor expression in isolated islets of db/db mice,” International Journal of Endocrinology, vol. 2013, Article ID 319586, 10 pages, 2013. View at Publisher · View at Google Scholar
  32. K. S. Yang, J. H. Lim, T. W. Kim et al., “Vascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db mice,” PLoS ONE, vol. 9, no. 4, Article ID e94540, 2014. View at Google Scholar
  33. Y. Sato-Miyata, K. Muramatsu, M. Funakoshi, M. Tsuda, and T. Aigaki, “Overexpression of dilp2 causes nutrient-dependent semi-lethality in Drosophila,” Frontiers in Physiology, vol. 5, article 147, 2014. View at Publisher · View at Google Scholar
  34. P. M. Vareda, L. L. Saldanha, N. A. Camaforte et al., “Myrcia bella leaf extract presents hypoglycemic activity via PI3k/Akt insulin signaling pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 543606, 2014. View at Publisher · View at Google Scholar
  35. R. Padiya, D. Chowdhury, and R. Borkar, “Garlic attenuates cardiac oxidative stress via activation of PI3K/AKT/Nrf2-Keap1 pathway in fructose-fed diabetic rat,” PLoS ONE, vol. 9, no. 5, Article ID e94228, 2014. View at Google Scholar
  36. M. P. Sajan and R. V. Farese, “Insulin signalling in hepatocytes of humans with type 2 diabetes: excessive production and activity of protein kinase C-ι (PKC-ι) and dependent processes and reversal by PKC-ι inhibitors,” Diabetologia, vol. 55, no. 5, pp. 1446–1457, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. C. C. Shih, M. H. Chen, and C. H. Lin, “Validation of the antidiabetic and hypolipidemic effects of Clitocybe nuda by assessment of glucose transporter 4 and gluconeogenesis and ampk phosphorylation in streptozotocin-induced mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 705636, 15 pages, 2014. View at Publisher · View at Google Scholar
  38. J. Guzman, A. N. Jauregui, and S. Merscher-Gomez, “Podocyte-specific GLUT4-deficient mice have fewer and larger podocytes and are protected from diabetic nephropathy,” Diabetes, vol. 63, no. 2, pp. 701–714, 2014. View at Google Scholar
  39. T. Schwasinger-Schmidt, D. C. Robbins, S. J. Williams, L. Novikova, and L. Stehno-Bittel, “Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats,” Pharmacological Research, vol. 76, pp. 58–66, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. M. H. Noyan-Ashraf, E. A. Shikatani, I. Schuiki et al., “A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity,” Circulation, vol. 127, no. 1, pp. 74–85, 2013. View at Publisher · View at Google Scholar · View at Scopus